To investigate whether the anticancer effect of gemcitabine in BLCA involves the MYCN-PKIB-PKA-HSP27 axis, we detected the protein expression of MYCN, PKIB, and HSP27 in gemcitabine-treated BLCA cells. The gene discussed is PKIB; the disease is bladder transitional cell carcinoma.